Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
3.140
0.00 (0.00%)
At close: May 8, 2026, 4:00 PM EDT
3.149
+0.009 (0.28%)
After-hours: May 8, 2026, 7:45 PM EDT
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $808.25 million as of May 8, 2026. Its market cap has increased by 363.71% in one year.
Market Cap
808.25M
Enterprise Value
1.20B
1-Year Change
363.71%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $808.25M, an increase of 296.01%. That is a compound annual growth rate of 11.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 808.30M | -8.62% |
| Dec 31, 2025 | 884.50M | 104.04% |
| Dec 31, 2024 | 433.50M | 27.50% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
| Jun 26, 2013 | 204.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 1.14B |
| Evotec SE | 1.11B |
| Amphastar Pharmaceuticals | 1.07B |
| Alvotech | 1.00B |
| Cronos Group | 994.40M |
| Pacira BioSciences | 930.18M |
| Eton Pharmaceuticals | 848.70M |
| BioAge Labs | 791.17M |